Correlation Between Chung Hwa and BenQ Medical

Can any of the company-specific risk be diversified away by investing in both Chung Hwa and BenQ Medical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chung Hwa and BenQ Medical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chung Hwa Chemical and BenQ Medical Technology, you can compare the effects of market volatilities on Chung Hwa and BenQ Medical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chung Hwa with a short position of BenQ Medical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chung Hwa and BenQ Medical.

Diversification Opportunities for Chung Hwa and BenQ Medical

0.75

Correlation Coefficient

Chung Hwa  BenQ Medical

Poor diversification

The 3 months correlation between Chung and BenQ is 0.75. Overlapping area represents the amount of risk that can be diversified away by holding Chung Hwa Chemical and BenQ Medical Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BenQ Medical Technology and Chung Hwa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chung Hwa Chemical are associated (or correlated) with BenQ Medical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BenQ Medical Technology has no effect on the direction of Chung Hwa i.e., Chung Hwa and BenQ Medical go up and down completely randomly.

Pair Corralation between Chung Hwa and BenQ Medical

Assuming the 90 days trading horizon Chung Hwa Chemical is expected to under-perform the BenQ Medical. In addition to that, Chung Hwa is 2.89 times more volatile than BenQ Medical Technology. It trades about -0.06 of its total potential returns per unit of risk. BenQ Medical Technology is currently generating about -0.05 per unit of volatility. If you would invest  5,040  in BenQ Medical Technology on September 13, 2024 and sell it today you would lose (180.00) from holding BenQ Medical Technology or give up 3.57% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Chung Hwa Chemical  vs.  BenQ Medical Technology

Chung Hwa Chemical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Chung Hwa Chemical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

BenQ Medical Technology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days BenQ Medical Technology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, BenQ Medical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Chung Hwa and BenQ Medical

The main advantage of trading using opposite Chung Hwa and BenQ Medical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chung Hwa position performs unexpectedly, BenQ Medical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BenQ Medical will offset losses from the drop in BenQ Medical's long position.

The idea behind Chung Hwa Chemical and BenQ Medical Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.